Sarepta Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Sarepta Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Sarepta Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Sarepta Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Sarepta Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| FI3297649T3 | Grant | Peptide oligonucleotide conjugates | A61K31/7088; A61K38/00; A61K47/18; A61K47/64; A61K47/645; A61P21/00; A61P21/04; A61P31/04; A61P31/12; C07K7/06; C07K7/08; Y02A50/30 | November 30, 2023 |
| US20230381216A1 | Application | Exon skipping oligomer conjugates for muscular dystrophy | C12N15/113; C12N2310/111; A61K31/712; A61K31/7125; A61K47/645; A61P21/00 | November 30, 2023 |
| EP4267191A1 | Application | Compositions comprising exon skipping oligonucleotide conjugates for treating muscular dystrophy | C12N15/113; C12N2310/11; C12N2310/3233; C12N2310/3513; C12N2320/33; A61K47/12; A61K47/26; A61K47/645; A61K9/0019; A61K9/19; A61P21/00 | November 01, 2023 |
| US11802283B2 | Grant | Oligonucleotide analogues targeting human lmna | C12N15/113; C12N2310/11; C12N2310/3183; C12N2310/323; C12N2310/3233; C12N2310/351; C12N2310/3513; C12N2320/33; A61P43/00; C07K7/06 | October 31, 2023 |
| JP7370344B2 | Grant | 筋ジストロフィーに対するエクソンスキッピングオリゴマーコンジュゲート | C12N15/111; C12N15/113; C12N15/62; C12N2310/11; C12N2310/3233; C12N2310/3513; C12N2320/33; A61K47/6455; A61K47/6807; A61K9/0019; A61P21/00; C07K14/4707 | October 27, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer